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Aim of the study. The aim of this review was to evaluate the current information regarding 
lactose intolerance in order to establish whether the prevalent misconception has scientific 
grounds.  
Materials and methods. An extensive English search was undertaken of the PubMed database 
for the terms “lactose intolerance”, “self-reported lactose intolerance”, and relevant articles 
from 2010-2020 were examined.  
Results. Lactose intolerance is associated with gastrointestinal symptoms with intra- and inter-
individual variability after ingestion of lactose-containing foods, this relation being influenced 
by: the expression of lactase, dose of lactose, intestinal flora, gut transit time, ingestion of other 
dietary components, the sensitivity of the gastrointestinal tract and the genetically programmed 
decrease in lactase synthesis. While lactose is the main factor considered, other maldigested 
carbohydrates, dairy related nutrients (some fats or casein proteins) and some gastrointestinal 
diseases may be taken in account.  A nocebo effect has also been considered to contribute to 
the exaggerated understanding of lactose intolerance, individuals erroneously attributing their 
symptoms to lactose consumption. Inappropriate avoidance of dairy products can lead to 
nutritional inadequacy, increasing the risk of osteoporosis, bone fractures, hypertension.  
Conclusions. The common wrong understanding of lactose intolerance has led to the 
increasing misleading self-diagnosis, a decision that results in a series of consequences 
associated with diet restrictions.  
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intolerance  
 
304. PHENOPTOSIS - BIOCHEMICAL MECHANISMS 
 
Author: Doina Dudnic  
Scientific adviser: Leonid Lîsîi, MD, PhD, University Professor, Department of Biochemistry 
and Clinical Biochemistry, Nicolae Testemitanu State University of Medicine and Pharmacy, 
Chisinau, Republic of Moldova 
 
Introduction.  In the last decades, we have witnessed a real "inflation" of medical discussions 
and research on science of longevity and anti-aging medicine. Understanding the aging process 
can offer us different solutions to slow down the process and enjoy health and vitality for a 
longer time.  
Aim of the study. Studying the biochemical mechanisms and the influence of the various 
factors in phenoptosis and description of the miraculous effects of antioxidant substances.  
Materials and methods.  Have been studied 17 articles from relevant scientific journals 
regarding the terms “phenoptosis”, “oxidative stress”, “reactive oxygen species”, 
“antioxidant”.  
Results.  After highlighting all the sequential steps in carrying out the aging program, we may 
deduce the important role of the mitochondria, as the energy supply stations of the cell, and at 
the same time, sources of free radical production. Lipid peroxidation exacerbates during the 
aging process in cells – increases the pro-oxidative capacity and decreases the antioxidant 
capacity. It was discovered the most effective protector against reactive oxygen species, the 
compound SkQ1, to which plastoquinone, the natural antioxidant of the plants, is attached. SkQ 
is able to delay the development of signs of aging and increase the life span of a large variety 
of animals.  
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Conclusions.  (1) Aging is a set of processes, each reducing the body's resistance. (2) 
Understanding the aging process, however, can provide us with different solutions to slow 
down the process and enjoy health and vitality for a longer time.  
Key words:  phenoptosis, oxidative stress, reactive oxygen species, antioxidant.  
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Introduction.  Gastroesophageal reflux disease is a common clinical pathology of the upper 
digestive tract, due to the reflux of the gastric or duodenal content within the esophagus, caused 
by a failure of the antireflux mechanisms, namely the lower esophageal sphincter.   
Aim of the study.  To study the clinical features, the diagnostic methods and the therapeutic 
treatment in patients with gastroesophageal reflux disease   
Materials and methods.  The retrospective study was conducted on 120 patients, admitted at 
the Department of Gastroenterology, within "Timofei Moșneaga" Republican Clinical 
Hospital. The study included two groups of patients: 60 patients, hospitalized during 2017-
2018 years and 60 patients admitted during 2018-2019, aged between 18- 80 years old. The 
data regarding the patients’ complaints, anamnesis, methods of diagnosis and treatment 
outcomes have been studied and interpreted.   
Results.  The study showed a higher incidence of female patients in both study groups. 
According to the age criterion, 33.33% of patients were aged between 51 -70 years old and 
only 1.66% - aged under 20. The most common patients ‘complaints (more than 50%) included 
as following: 85.8% of cases presented epigastric pain, 53.3% - belching and 52.5%- heartburn 
, followed by 48.3%- mouth bitterness, 44.1 % - nausea and 30.8% -bloating. The least recorded 
complaints were regurgitations in 5% of cases and dysphagia - 4.1%. Both groups of patients 
were diagnosed based on the presence of the classic symptoms of GERD, positive response to 
PPI treatment, upper digestive endoscopy and chest X-ray assessment. According to the study, 
during the period 2017 -2018, the treatment of patients with GERD was mainly aimed at 
reducing the gastric acid secretion by administering omeprazole - 71.7% and pantoprazole - 
18.4%. In 2018-2019 years, patients with GERD underwent a treatment for increasing the 
intestinal motility, by administrating metoclopramide - 68.4%, followed by the proton pump 
inhibitors -pantoprazole - 30%, omeprazole - 21.7% and antacids - 28.4%.   
Conclusions.  The study of the gastroesophageal reflux disease particularities in patients from 
the Department of Gastroenterology has proved that the diagnosis should be based on the 
presence of the classic symptoms, changes detected in the upper digestive endoscopy and the 
presence of the reflux on the chest X-Ray assessment. The treatment regimens included both 
the suppression of gastric acidic secretion and the increase of the intestinal motility, thus 
diminishing the action of the harmful factors on LES and esophageal mucosa.   
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